Detalhe da pesquisa
1.
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
N Engl J Med
; 387(21): 1923-1934, 2022 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36342113
2.
Comparison of the safety, tolerability, and pharmacokinetic profile of a single oral dose of pitavastatin 4 mg in adult subjects with severe renal impairment not on hemodialysis versus healthy adult subjects.
J Cardiovasc Pharmacol
; 60(1): 42-8, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22472908
3.
Pitavastatin versus pravastatin in adults with HIV-1 infection and dyslipidaemia (INTREPID): 12 week and 52 week results of a phase 4, multicentre, randomised, double-blind, superiority trial.
Lancet HIV
; 4(7): e284-e294, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28416195
4.
Comparison of the lipid-lowering effects of pitavastatin 4 mg versus pravastatin 40 mg in adults with primary hyperlipidemia or mixed (combined) dyslipidemia: a Phase IV, prospective, US, multicenter, randomized, double-blind, superiority trial.
Clin Ther
; 36(8): 1211-22, 2014 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24998014
5.
Steady-state pharmacokinetics of darunavir/ritonavir and pitavastatin when co-administered to healthy adult volunteers.
Clin Drug Investig
; 34(7): 475-82, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24825411
6.
Effects of steady-state lopinavir/ritonavir on the pharmacokinetics of pitavastatin in healthy adult volunteers.
J Acquir Immune Defic Syndr
; 60(2): 158-64, 2012 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22627182
7.
Effect of pitavastatin vs. rosuvastatin on international normalized ratio in healthy volunteers on steady-state warfarin.
Curr Med Res Opin
; 28(2): 187-94, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22149769